ADHD, growth deficits, and relationships to psychostimulant use.
Joshi
Shashank V
SV
ADHD/Disruptive Behavior Disorders Clinic Stanford University School of Medicine Stanford, CA, USA.
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002648:Child; D003913:Dextroamphetamine / Q000009:adverse effects; D006130:Growth Disorders / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects; D028761:Withholding Treatment
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003913:Dextroamphetamine